Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (111)

1

Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF

enthalten in: Journal of the American College of Cardiology | 2024

von Kondo, T. | Mogensen, U. | Talebi, A. | +15

2

Dapagliflozin and Timing of Prior Heart Failure Hospitalization : A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

enthalten in: JACC. Heart failure | 2024

von Butt, J. | Jhund, P. | Docherty, K. | +15

3

Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations

enthalten in: JACC. Heart failure | 2024

von Adamson, P. | Echols, M. | DeFilippis, E. | +14

4

Sodium Glucose Co-Transporter 2 Inhibition Following Acute Myocardial Infarction : The DAPA-MI and EMPACT-MI Trials

enthalten in: JACC. Heart failure | 2024

von Peikert, A. | Vaduganathan, M.

5

Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction

enthalten in: Journal of the American College of Cardiology | 2024

von Foà, A. | Vaduganathan, M. | Claggett, B. | +12

6

Contemporary American and European Guidelines for Heart Failure Management : JACC: Heart Failure Guideline Comparison

enthalten in: JACC. Heart failure | 2024

von Ostrominski, J. | DeFilippis, E. | Bansal, K. | +4

7

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction : An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

enthalten in: Journal of the American Heart Association | 2024

von Bhatt, A. | Vaduganathan, M. | Claggett, B. | +13

8

Formative Perceptions of a Digital Pill System to Measure Adherence to Heart Failure Pharmacotherapy : Mixed Methods Study

enthalten in: JMIR cardio | 2024

von Chai, P. | Kaithamattam, J. | Chung, M. | +7

9

Effects of Dapagliflozin in Patients in Asia : A Post Hoc Subgroup Analysis From the DELIVER Trial

enthalten in: JACC. Asia | 2024

von Wang, X. | Lam, C. | Vaduganathan, M. | +18

10

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

enthalten in: Circulation | 2024

von Neuen, B. | Heerspink, H. | Vart, P. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]